These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6790991)

  • 1. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
    Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro lymphocyte toxicity to a phenytoin metabolite in phenytoin induced cutaneous adverse drug eruptions.
    Dwivedi R; Gogtay N; Kharkar V; Amladi S; Kshirsagar N
    Indian J Dermatol Venereol Leprol; 2004; 70(4):217-20. PubMed ID: 17642618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
    Shear NH; Spielberg SP
    J Clin Invest; 1988 Dec; 82(6):1826-32. PubMed ID: 3198757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
    Gordon GB; Spielberg SP; Blake DA; Balasubramanian V
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2545-8. PubMed ID: 6941308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant toxicity in vitro: possible role of arene oxides.
    Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS
    J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.
    Gerson WT; Fine DG; Spielberg SP; Sensenbrenner LL
    Blood; 1983 May; 61(5):889-93. PubMed ID: 6831050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial occurrence of hypersensitivity to phenytoin.
    Gennis MA; Vemuri R; Burns EA; Hill JV; Miller MA; Spielberg SP
    Am J Med; 1991 Dec; 91(6):631-4. PubMed ID: 1750433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane hepatitis. Detection of a constitutional susceptibility factor.
    Farrell G; Prendergast D; Murray M
    N Engl J Med; 1985 Nov; 313(21):1310-4. PubMed ID: 4058523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone.
    Yokoi T
    Handb Exp Pharmacol; 2010; (196):419-35. PubMed ID: 20020270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans.
    Spielberg SP
    Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital.
    Kahn HD; Faguet GB; Agee JF; Middleton HM
    Arch Intern Med; 1984 Aug; 144(8):1677-9. PubMed ID: 6466024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro analysis of idiosyncratic drug reactions.
    Spielberg SP
    Clin Biochem; 1986 Apr; 19(2):142-4. PubMed ID: 3708795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil.
    Spielberg SP; Shear NH; Cannon M; Hutson NJ; Gunderson K
    Ann Intern Med; 1991 May; 114(9):720-4. PubMed ID: 2012352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased microsomal irreversible binding of phenytoin by valproic acid.
    Wang SL; Lai ML; Huang JD
    Biochem Pharmacol; 1991 Aug; 42(5):1143-4. PubMed ID: 1872899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs.
    Santos NA; Medina WS; Martins NM; Rodrigues MA; Curti C; Santos AC
    Toxicol In Vitro; 2008 Dec; 22(8):1820-4. PubMed ID: 18783732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
    Martz F; Failinger C; Blake DA
    J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylhydantoin-induced hepatotoxicity.
    Aaron JS; Bank S; Ackert G
    Am J Gastroenterol; 1985 Mar; 80(3):200-2. PubMed ID: 3976639
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenytoin-induced hypersensitivity reactions.
    Prosser TR; Lander RD
    Clin Pharm; 1987 Sep; 6(9):728-34. PubMed ID: 3677571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to phenytoin-induced birth defects.
    Strickler SM; Dansky LV; Miller MA; Seni MH; Andermann E; Spielberg SP
    Lancet; 1985 Oct; 2(8458):746-9. PubMed ID: 2864485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.